Insulet Corporation

NMS: PODD

Live Quote

📈 ZcoreAI Score

Our AI model analyzes Insulet Corporation's price action across multiple timeframes using regression channels and statistical scoring.

Get PODD Z-Score →

About Insulet Corporation

Healthcare Medical Devices

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

📊 Fundamental Analysis

Insulet Corporation demonstrates a profit margin of 9.1%, which is below the sector average, suggesting competitive pressure.

The company recently reported 31.2% revenue growth, which is well above average for the Healthcare sector.

Return on Equity (ROE) is 18.1%, which exceeds the Healthcare sector average, reflecting efficient capital allocation.

At a current price of $196.93, PODD currently trades near the bottom of its 52-week range (1%), indicating potential value or weakness (Range: $195.28 - $354.88).

💰 Valuation Insight

PODD trades at a 125.7% premium to the sector average PE of 25.00. Analysts expect earnings growth, as indicated by a lower forward PE.

🏥 Financial Health

🔴 Profit Margin Weak

🔴 Debt/Equity Elevated

✅ Revenue Growth Excellent

⚠️ Return on Equity Moderate

🔴 Beta (Risk) High Volatility

Key Financials

Market Cap

$13.86B

Trailing P/E

56.43

Forward P/E

24.37

Beta (5Y)

1.47

52W High

$354.88

52W Low

$195.28

Avg Volume

1.05M

Day High

Day Low

Get PODD Z-Score on Dashboard 🚀